AIM
ATRC icon

Acrospire Investment Management’s AtriCure ATRC Stock Holding History

Acrospire Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,677
Closed -$41K – 116
2017
Q2 		$41K Buy
1,677
+1,300
+345% +$27.6K 0.04% 1037
2017
Q1 		$7K Buy
+377
New +$6.61K 0.01% 1929

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acrospire Investment Management's ATRC Position: Q3 2017 in Review

Acrospire Investment Management sold out of AtriCure (ATRC) in Q3 2017, closing a stake of 1,677 shares — an estimated $41K sold.

Acrospire Investment Management first reported a position in ATRC in Q1 2017 and held it in 2 quarters. The position peaked at $41K in Q2 2017. 114 funds tracked by Wall St. Rank hold ATRC as of Q3 2017.

  • Acrospire Investment Management reported no remaining AtriCure position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,677 AtriCure shares in Q3 2017, an estimated $41K.
  • Acrospire Investment Management first reported a position in AtriCure in Q1 2017 and held it in 2 quarters.
  • Acrospire Investment Management's AtriCure position peaked at $41K in Q2 2017.
  • 114 funds tracked by Wall St. Rank held AtriCure as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.